Studies on leptin, which is a protein hormone secreted by adipocytes, and identified as a candidate biomarker for breast cancer progression, have shown unconvincing results, and none of the hypotheses concerning the role of leptin or other adipokines in breast cancer progression have been totally conclusive. The gene discussed is LEP; the disease is breast cancer.